Philippe Panchaud

Philippe Panchaud is a seasoned professional in the pharmaceutical industry, currently serving as Senior Director and Group Leader for Preformulation and Preclinical Galenics at Idorsia Pharmaceuticals Ltd since June 2017. In this role, responsibilities encompass leading a team of scientists focused on technical development of new molecules, budget management, and talent development. Philippe has previously held various leadership roles in both preclinical development and drug discovery within Actelion and has extensive experience in synthetic organic and medicinal chemistry, with postdoctoral research at Stanford University and the University of Bern. Educational qualifications include a PhD in Organic Chemistry and participation in several leadership programs.